US FDA Ready To Accept 510(k) Devices To Expedited Access/Breakthrough Pathway

Manufacturers considering the Expedited Access Pathway for 510(k) devices should start the submission process, experts and agency staff say, although it still remains to be seen what types of 510(k) devices will qualify. The December-enacted 21st Century Cures Act added 510(k) devices to the program as part of its Breakthrough Device provision.

MT1705_Business-Opportunity_544079215-_1200x675

FDA is ready to implement a clause in the 21st Century Cures Act that requires the agency to accept 510(k) devices into the Expedited Access Pathway (EAP) for breakthrough devices, agency staff says. What types of 510(k) devices might qualify for the program in practice remains to be seen, but experts suggest devices that offer significant benefits to patients, even if not completely new, may be the most likely participants.

Introduced by FDA in 2015, EAP offers a faster development path to market for some devices that significantly improve treatment...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Regulation

More from Policy & Regulation